Overview

Study Of Single Doses Of PF-06291826 (Tafamidis) In Japanese And Western Subjects

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is the following: - To evaluate the safety, tolerability, and pharmacokinetics (PK) of orally administered tafamidis in Japanese and Western healthy volunteers at single dose. - To compare Japanese and Western PK profiles. - Determine the PD stabilization effect of tafamidis on human transthyretin (TTR) in a validated ex vivo assay.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer